Get the Stockscreener App
2.9908
0.17%
-0.0008
Organogenesis Holdings Inc stock is traded at $2.9908, with a volume of 70,561.
It is down -0.17% in the last 24 hours and down -3.08% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
See More
Previous Close:
$2.99
Open:
$2.97
24h Volume:
70,561
Relative Volume:
0.14
Market Cap:
$401.70M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
36.65
EPS:
0.0816
Net Cash Flow:
$6.55M
1W Performance:
+0.17%
1M Performance:
-3.08%
6M Performance:
+19.88%
1Y Performance:
+25.95%
1-Day Range:
$2.96
$3.0693
1-Week Range:
$2.75
$3.0693
52-Week Range:
$1.96
$4.705
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Organogenesis (ORGO) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
Organogenesis Holdings And 2 Other US Penny Stocks To Watch - Simply Wall St
Mass. company offered millions to manufacture artificial skin in the Ocean StateProvidence Business First - The Business Journals
Business | McKee Administration Poised to Give Major Incentives to Boston Biotech Firm - GoLocalProv
Organogenesis eyes former Rubius site in SmithfieldProvidence Business First - The Business Journals
Mass.-based biotech firm looks to expand to former Rubius facility in Smithfield - Providence Business News
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested three years ago - Yahoo Finance
Assenagon Asset Management S.A. Has $5.48 Million Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 - The Manila Times
Market Highlights: Organogenesis Holdings Inc (ORGO) Ends on a High Note at 3.09 - The Dwinnex
Cubist Systematic Strategies LLC Acquires 88,175 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis: Lurking Disruption With Recovery To Follow (NASDAQ:ORGO) - Seeking Alpha
Cantor Fitzgerald Comments on Organogenesis Holdings Inc.'s FY2024 Earnings (NASDAQ:ORGO) - MarketBeat
Amniotic Membrane Market to See Booming Growth 2024-2031 | Smith - openPR
Dimensional Fund Advisors LP Raises Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Purchased by AQR Capital Management LLC - Defense World
AQR Capital Management LLC Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers - ForexTV.com
Healthy Upside Potential: Organogenesis Holdings Inc (ORGO) - SETE News
Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Update - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Massachusetts Financial Services Co. MA - Defense World
Bank of New York Mellon Corp Increases Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
WINTON GROUP Ltd Sells 4,139 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Are Organogenesis Holdings Inc’shares a good deal? - US Post News
Wealth Dimensions Group Ltd. Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Acadian Asset Management LLC Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Why Investors Shouldn't Be Surprised By Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Low P/S - Simply Wall St
Wound Care Biologics Market Business Strategies, Share, Growth - openPR
Ratio Revelations: Organogenesis Holdings Inc (ORGO)’s Financial Metrics in the Spotlight - The Dwinnex
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - ForexTV.com
Organogenesis Holdings Inc’s results are impressive - US Post News
Comprehensive Study of Asia Pacific Wound Care Biologics Market - openPR
There is no doubt that Organogenesis Holdings Inc (ORGO) ticks all the boxes. - SETE News
Examining Organogenesis Holdings Inc (ORGO) stock is warranted - US Post News
Financial Analysis: Organogenesis Holdings Inc (ORGO)’s Ratios Unveil Key Insights - The Dwinnex
Organogenesis Holdings Inc (ORGO) expanding its growth trajectory ahead - SETE News
Assenagon Asset Management S.A. Purchases 3,005,450 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Vanguard Group Inc. Sells 1,825,428 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc (ORGO) presents a great opportunity, but the stock is slightly overvalued - US Post News
Company’s Banking Shares: Up -43.46% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class ActionORGO - Marketscreener.com
Market Highlights: Organogenesis Holdings Inc (ORGO) Ends on a Low Note at 2.42 - The Dwinnex
Organogenesis Holdings Second Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.04 profit in 2Q 2023) - Simply Wall St
Organogenesis Holdings Inc (ORGO) can make a big difference with a little luck - SETE News
Organogenesis Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Organogenesis exceeds Q2 revenue expectation at $130.2 million - Investing.com
Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results - ForexTV.com
Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail
Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail
Organogenesis (ORGO) Q2 2024 Earnings Call Transcript - The Motley Fool
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organogenesis Holdings Inc Stock (ORGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ERANI ALBERT | 10% Owner |
Jan 09 '24 |
Sale |
4.37 |
197,921 |
863,985 |
59,025,106 |
| ERANI ALBERT | 10% Owner |
Jan 10 '24 |
Sale |
4.28 |
17,972 |
76,875 |
59,007,134 |
| ERANI ALBERT | 10% Owner |
Jan 09 '24 |
Sale |
4.37 |
197,921 |
863,985 |
59,025,106 |
| ERANI ALBERT | 10% Owner |
Jan 10 '24 |
Sale |
4.28 |
17,972 |
76,875 |
59,007,134 |
1.16%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):